ASRT
Price
$0.65
Change
-$0.02 (-2.99%)
Updated
Jul 3 closing price
Capitalization
91.13M
24 days until earnings call
TXMD
Price
$1.18
Change
+$0.04 (+3.51%)
Updated
Jul 3 closing price
Capitalization
24.32M
42 days until earnings call
Interact to see
Advertisement

ASRT vs TXMD

Header iconASRT vs TXMD Comparison
Open Charts ASRT vs TXMDBanner chart's image
Assertio Holdings
Price$0.65
Change-$0.02 (-2.99%)
Volume$125.87K
Capitalization91.13M
TherapeuticsMD
Price$1.18
Change+$0.04 (+3.51%)
Volume$22.46K
Capitalization24.32M
ASRT vs TXMD Comparison Chart in %
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. TXMD commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Buy and TXMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ASRT: $0.65 vs. TXMD: $1.18)
Brand notoriety: ASRT and TXMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 49% vs. TXMD: 41%
Market capitalization -- ASRT: $91.13M vs. TXMD: $24.32M
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. TXMD’s [@Pharmaceuticals: Other] market capitalization is $24.32M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, TXMD is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 3 TA indicator(s) are bullish while TXMD’s TA Score has 6 bullish TA indicator(s).

  • ASRT’s TA Score: 3 bullish, 5 bearish.
  • TXMD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TXMD is a better buy in the short-term than ASRT.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а +0.32% price change this week, while TXMD (@Pharmaceuticals: Other) price change was +0.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

TXMD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASRT($91.1M) has a higher market cap than TXMD($24.3M). ASRT has higher P/E ratio than TXMD: ASRT (1.21) vs TXMD (0.47). TXMD YTD gains are higher at: 37.209 vs. ASRT (-25.037). TXMD has higher annual earnings (EBITDA): 52.6M vs. ASRT (-222.9M). ASRT has more cash in the bank: 73.4M vs. TXMD (10.2M). TXMD has less debt than ASRT: TXMD (8.2M) vs ASRT (39.7M). ASRT has higher revenues than TXMD: ASRT (152M) vs TXMD (69.4M).
ASRTTXMDASRT / TXMD
Capitalization91.1M24.3M375%
EBITDA-222.9M52.6M-424%
Gain YTD-25.03737.209-67%
P/E Ratio1.210.47255%
Revenue152M69.4M219%
Total Cash73.4M10.2M720%
Total Debt39.7M8.2M484%
FUNDAMENTALS RATINGS
ASRT vs TXMD: Fundamental Ratings
ASRT
TXMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
6452
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXMD's Valuation (48) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ASRT (82) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew somewhat faster than ASRT’s over the last 12 months.

TXMD's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

TXMD's SMR Rating (92) in the Pharmaceuticals Generic industry is in the same range as ASRT (95) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

TXMD's Price Growth Rating (52) in the Pharmaceuticals Generic industry is in the same range as ASRT (64) in the Pharmaceuticals Major industry. This means that TXMD’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as TXMD (100) in the Pharmaceuticals Generic industry. This means that ASRT’s stock grew similarly to TXMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTTXMD
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
73%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
68%
MACD
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
63%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 5 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLO11.450.29
+2.60%
DLocal Limited
OVID0.340.01
+2.39%
Ovid Therapeutics
ALL198.003.31
+1.70%
Allstate Corp (The)
OCS19.00-0.16
-0.81%
Oculis Holding AG
SLI2.21-0.02
-0.90%
Standard Lithium Ltd

ASRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASRT has been loosely correlated with PAIOF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ASRT jumps, then PAIOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-3.23%
PAIOF - ASRT
34%
Loosely correlated
N/A
RGEDF - ASRT
31%
Poorly correlated
N/A
AQST - ASRT
30%
Poorly correlated
+1.09%
OGI - ASRT
28%
Poorly correlated
+3.62%
TLRY - ASRT
26%
Poorly correlated
+11.03%
More

TXMD and

Correlation & Price change

A.I.dvisor tells us that TXMD and TLRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TXMD and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
+3.51%
TLRY - TXMD
29%
Poorly correlated
+11.03%
ASRT - TXMD
27%
Poorly correlated
-3.23%
SCYX - TXMD
24%
Poorly correlated
+1.57%
TLPH - TXMD
23%
Poorly correlated
N/A
RMTI - TXMD
22%
Poorly correlated
+0.56%
More